Thank you, Ted. As I typically do, I'll cover the following topics during this portion of the call. I'll cover an overview of our 2023 fourth quarter results, along with an overview of related key operating statistics. I'll also cover an overview of our cash flow activities during the quarter, and I'll conclude with a discussion on our financial outlook for the first quarter of 2024. For purposes of this call, I will comment separately regarding the revenues of our Global S&BT segment, our Oracle Solutions segment, our SAP Solutions segment and the total company. Our Global S&BT segment includes the results of our North America and international IPaaS and benchmark offerings, our executive advisory programs, our business transformation and our OneStream and group offerings. Our Oracle Solutions and our SAP Solutions segments include the results of our Oracle and SAP offerings, respectively. Please note that we will be referencing both total revenues and revenues before reimbursements in our discussion. Reimbursable expenses are primarily project travel-related expenses passed through to our clients that have no associated impact to our profitability. During our call today, we will also reference certain non-GAAP financial measures, which we believe provide useful information to investors. We have included reconciliations of GAAP to non-GAAP financial measures in our press release filed earlier today and will post any additional information based on the discussion from this call to the Investor Relations page of the company's website. For the fourth quarter of 2023, as Ted mentioned, our total revenue was $72.4 million, up 3% over the prior year. Our revenues before reimbursements were $71.2 million, which was also above the high-end of our quarterly guidance, up 3% over the prior year. The fourth quarter reimbursable expense ratio on revenues before reimbursements was 1.7% as compared to 1.6% in the prior quarter and 1.9% when compared to the same period in the prior year. Total revenues from our Global S&BT segment were $42.2 million for the fourth quarter of 2023. Revenues before reimbursements for our Global S&BT segment were $41.6 million for the fourth quarter of '23, an increase of 3% when compared to the same period in the prior year. Total revenues from our Oracle Solutions segment were $19 million for the fourth quarter of 2023. Revenues before reimbursements for our Oracle Solutions segment were $18.4 million for the fourth quarter, an increase of 10.6% when compared to the same period in the prior year. This is consistent with the momentum we've experienced since the second quarter of '23, with strong double-digit growth over the last two quarters when compared to prior year periods. Total revenues from our SAP Solutions segment were $11.2 million for the fourth quarter of '23. Revenues before reimbursements for our SAP Solutions segment were $11.1 million for the fourth quarter, a decrease of 5% when compared to the same period in the prior year, consistent with the guidance we provided last quarter. The sales investments we made during '23 are expected to contribute to growth in 2024. Approximately 24% of our total company revenues before reimbursements consist of recurring multiyear and subscription-based revenues, which includes our executive advisory, IP as a service, multiyear benchmarks and application managed services contracts. Total company adjusted cost of sales, which exclude reimbursable expenses and noncash stock-based compensation expense, totaled $40.3 million or 56.7% of revenues before reimbursements in the fourth quarter of 2023 as compared to $37.8 million or 54.9% of revenues before reimbursements in the prior year. Total company consultant headcount was 1,168 at the end of the fourth quarter as compared to a total company consultant headcount of 1,177 in the previous quarter and 1,128 at the end of the fourth quarter of the prior year. Total company adjusted gross margin on revenues before reimbursements, which excludes reimbursable expenses and noncash stock-based compensation expense was 43.3% in the fourth quarter of 2023 as compared to 45.1% in the prior year period. This decrease is primarily due to increased head count and lower utilization in the fourth quarter. Adjusted SG&A, which excludes noncash stock-based compensation expense and our Gartner legal settlement and related costs, was $15.4 million or 21.6% of revenues before reimbursements in the fourth quarter of '23. This is compared to $14.9 million or 21.7% of revenues before reimbursements in the prior year. The year-over-year absolute dollar increase is primarily due to incremental investments we are making and dedicated sales resources for executive advisory service offerings. These investments approximated $0.01 in the fourth quarter of 2023. Adjusted EBITDA, which excludes noncash stock-based compensation expense and the one-time legal settlement previously mentioned and related costs, was $16.3 million or 23% of revenues before reimbursements in the fourth quarter of '23 as compared to $16.9 million or 24.5% of revenues before reimbursements in the prior year. GAAP net income for the fourth quarter of '23 totaled $7.9 million with diluted earnings per share of $0.28 in compares to GAAP net income of $9.7 million or diluted earnings per share of $0.31 in the fourth quarter of the previous year. GAAP net income includes a one-time legal settlement and related costs of $1.2 million or $0.03 per diluted earnings per share. Adjusted net income, which excludes noncash stock-based compensation expense and the legal settlement for the fourth quarter of 2023, totaled $10.8 million or adjusted diluted net income per common share of $0.39, which was above the high-end of our earnings guidance range. This compares to adjusted net income of $11.5 million or adjusted diluted net income per common share of $0.36 in the fourth quarter of the prior year. The company's cash balances were $21 million at the end of the fourth quarter of '23 as compared to $9.9 million at the end of the previous quarter. Net cash provided by operating activities in the quarter was $25.6 million, primarily driven by net income adjusted for noncash activity and decreases in accounts receivable and related days sales outstanding. Our DSO at the end of the quarter was 65 days as compared to 75 days at the end of the previous quarter and as compared to 63 days at the end of the fourth quarter of 2022. During the quarter, the company paid down $11 million on our credit facility. The balance of the company's total debt outstanding at the end of the fourth quarter was approximately $33 million. Net interest expense for the quarter was $641,000. During the quarter, we repurchased approximately 3,000 shares of the company's stock from employees to satisfy income tax withholding triggered by the vesting of restricted stock -- of restricted shares for an average of $23.08 per share at a total cost of approximately $71,000. Our remaining stock repurchase authorization at the end of the quarter was $13.9 million. At its most recent meeting, subsequent to the end of the quarter, the company's Board of Directors declared the first quarterly dividend of $0.11 per share for its shareholders of record on March 22, 2024, to be paid on April 5, 2024. I'm now going to move to discussing the guidance for our first quarter of 2024. Before I do that, I'd like to remind everyone of the seasonality of our business relative to costs as we move sequentially from Q4 to Q1. Specifically, consistent with first quarter guidance provided in previous years, our first quarter guidance for 2024 will reflect the sequential increase in U.S. payroll-related taxes and the sequential buildup of our vacation accruals. The company estimates total revenue before reimbursements for the first quarter of 2024 to be in the range of $72.5 million to $74 million. We expect all three segment revenues before reimbursements to be up when compared to the prior year with Oracle Solutions up strongly. We estimate adjusted diluted net income per common share in the first quarter of 2024 to be in the range of $0.36 to $0.39, which assumes a GAAP effective tax rate on adjusted earnings of 22%. We expect adjusted gross margin on revenues before reimbursements to be approximately 40.6% to 41.4%. We expect adjusted SG&A and interest expense to be approximately $16.8 million. We expect first quarter adjusted EBITDA on revenues before reimbursements to in the range of approximately 20% to 21%. Lastly, we expect cash balances, excluding the impact of share buyback activity, to be tempered due to the payment of 2023 performance related bonuses and the payment of the employee income taxable withholding triggered by net vesting of restricted shares. At this point, I would like to turn it back over to Ted to review our market outlook and our strategic priorities for the coming months. Ted?